Entry |
|
Symbol |
MAP2K6
|
Name |
(RefSeq) dual specificity mitogen-activated protein kinase kinase 6 isoform X4
|
KO |
|
Organism |
mcf Macaca fascicularis (crab-eating macaque)
|
Pathway |
mcf04620 | Toll-like receptor signaling pathway |
mcf04664 | Fc epsilon RI signaling pathway |
mcf04750 | Inflammatory mediator regulation of TRP channels |
mcf04935 | Growth hormone synthesis, secretion and action |
mcf05022 | Pathways of neurodegeneration - multiple diseases |
mcf05163 | Human cytomegalovirus infection |
mcf05167 | Kaposi sarcoma-associated herpesvirus infection |
mcf05170 | Human immunodeficiency virus 1 infection |
mcf05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
mcf05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:mcf00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
101925060 (MAP2K6)
04015 Rap1 signaling pathway
101925060 (MAP2K6)
04668 TNF signaling pathway
101925060 (MAP2K6)
09140 Cellular Processes
09143 Cell growth and death
04218 Cellular senescence
101925060 (MAP2K6)
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
101925060 (MAP2K6)
04664 Fc epsilon RI signaling pathway
101925060 (MAP2K6)
09152 Endocrine system
04912 GnRH signaling pathway
101925060 (MAP2K6)
04935 Growth hormone synthesis, secretion and action
101925060 (MAP2K6)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
101925060 (MAP2K6)
09158 Development and regeneration
04380 Osteoclast differentiation
101925060 (MAP2K6)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
101925060 (MAP2K6)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
101925060 (MAP2K6)
05161 Hepatitis B
101925060 (MAP2K6)
05163 Human cytomegalovirus infection
101925060 (MAP2K6)
05167 Kaposi sarcoma-associated herpesvirus infection
101925060 (MAP2K6)
05169 Epstein-Barr virus infection
101925060 (MAP2K6)
09171 Infectious disease: bacterial
05132 Salmonella infection
101925060 (MAP2K6)
05135 Yersinia infection
101925060 (MAP2K6)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
101925060 (MAP2K6)
09164 Neurodegenerative disease
05014 Amyotrophic lateral sclerosis
101925060 (MAP2K6)
05022 Pathways of neurodegeneration - multiple diseases
101925060 (MAP2K6)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
101925060 (MAP2K6)
05418 Fluid shear stress and atherosclerosis
101925060 (MAP2K6)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
101925060 (MAP2K6)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:mcf01001]
101925060 (MAP2K6)
Enzymes [BR:mcf01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.12 Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
2.7.12.2 mitogen-activated protein kinase kinase
101925060 (MAP2K6)
Protein kinases [BR:mcf01001]
Serine/threonine kinases: STE group
STE7 family
101925060 (MAP2K6)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
16:join(75738360..75738375,75832647..75832713,75844005..75844053,75844637..75844750,75846484..75846603,75847440..75847556,75848220..75848271,75850870..75850997,75852258..75852335,75853910..75854049,75863436..75863481,75869071..75869148)
|
AA seq |
334 aa
MSQSKGKKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELG
RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF
REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV
KPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDI
WSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSK
ERPTYPELMQHPFFTLHESKGTDVASFVKLILGD |
NT seq |
1005 nt +upstreamnt +downstreamnt
atgtctcagtcgaaaggcaagaagcgaaaccctggccttaaaattccaaaagaagcattt
gagcaacctcagaccagttccacaccacctcgagatttagactccaaggcttgcatttct
attggaaatcagaactttgaggtgaaggcagatgacctagagcctataatggaactggga
cgaggtgcgtacggggtggtggagaagatgcggcacgtgcccagcgggcagatcatggca
gtgaagcggattcgagccacagtaaatagccaggaacagaaaaggctactgatggatttg
gatatttccatgaggacggtggactgtccattcaccgtcaccttttatggcgcactgttt
cgggagggtgatgtgtggatctgcatggagctcatggacacatcactagataaattctac
aaacaagttattgataaaggccagacaattccagaggacatcttagggaaaatagcagtt
tctattgtaaaagcattagaacatttacacagtaagctgtctgtcattcacagagacgtc
aagccttctaatgtactcattaatgctctcggtcaagtgaagatgtgcgattttggaatc
agtggctacttggtggactctgttgctaaaacaattgatgcgggttgcaaaccatacatg
gcccctgaaagaataaacccagagctcaaccagaagggatacagtgtgaagtctgacatt
tggagtctgggcatcacgatgattgagttggccatccttcgatttccctatgattcctgg
ggaactccatttcagcagctcaaacaggtggtagaggagccatctccacaactcccagca
gacaagttctctgcagagttcgttgactttacctcacagtgcttaaagaagaattccaaa
gaacggcctacatacccagagctaatgcaacatccatttttcaccctacatgaatccaaa
ggaacagatgtggcatcttttgtaaaactgattcttggagattaa |